A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo

Published:2011-11-03 Issue:5 Volume:61 Page:677-687
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Lin Jinpiao,Huo Rongfen,Wang Li,Zhou Zhou,Sun Yue,Shen Baihua,Wang Rongfang,Li Ningli

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-011-1135-y.pdf

Reference45 articles.

1. Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33(10):461–473

2. Brigstock DR (1999) The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20(2):189–206

3. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95(11):6355–6360

4. Brigstock DR (2003) The CCN family: a new stimulus package. J Endocrinol 178(2):169–175

5. Menendez JA, Mehmi I, Griggs DW, Lupu R (2003) The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. Endocr Relat Cancer 10(2):141–152

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity;Journal of Cancer Research and Clinical Oncology;2024-03-26

2. Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer;Journal of Personalized Medicine;2023-01-14

3. Serum CYR61 as a potential biomarker to improve breast cancer diagnostics;Biomarkers in Medicine;2022-10

4. A zebrafish embryo screen utilizing gastrulation for identification of anti-metastasis drugs;2022-05-07

5. Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence;Oncogene;2022-01-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3